natural history of arteriovenous malformations. Many of the prognostic opinions in the literature are based largely on experience during the pre-angiographic era. The statement by Olivecrona and Riives that practically all patients die of an intracerebral hemorrhage or become incapacitated is not totally accurate. As a result of a study of a large number of artefiovenous malformations in a relatively small stable population, we believe that our series should contribute to the general knowledge of this disease. In addition, a large number of these patients have had one or more radioisotopic brain scans, and the accuracy of this diagnostic procedure in arteriovenous malformations has been reviewed.
Case Material
There have been 70 cases at the North Carolina Baptist Hospital from 1949 to 1969. Each patient who is alive has had a follow-up examination in recent months. There were 57 hemispheric lesions; 8 central lesions primarily in the thalamus, basal ganglion, and midbrain; and 5 lesions in the posterior fossa. Thus, they occurred in any part of the brain, but an overwhelming proportion were located in the cerebral hemispheres and the majority in or near the region supplied by branches of the middle cerebral artery.
The age of onset of symptoms varied in our patients from 4 to 78 years. The average age was 30, an interesting fact when one realizes that these are congenital lesions. The average age at diagnosis was 34.5 years.
Clinical Signs
The initial symptom usually was either an intracranial hemorrhage or a seizure (Table  1) .
Hemorrhage. Table 2 shows a detailed analysis of the patients with hemorrhage. The number of separate subarachnoid or intracerebral hemorrhages ranges from one to eight. The number of patients in each group, degree of disability, and number of deaths are listed. Those patients operated on are shown in the last column. These data show that the prognosis following hemorrhage secondary to arteriovenous malformation is variable. A patient may die from the initial hemorrhage or survive without deficit. As time passes, subsequent hemorrhages may be expected, with gradually increasing morbidity and mortality; however, some patients have survived for many years following several hemorrhages. The prognosis following hemorrhage could not be correlated with the location or size of the lesion or the age of the patient.
The over-all results for those patients with hemorrhage and without operation include 33 patients followed for an average of 15.5 years (Table 3 ). There have been 9 deaths, or a mortality of 28%; 2 patients are very disabled, and 4 are partially disabled; 18 patients (50%) have little if any disability and are employed full time.
Of these 33 patients, 14 have been followed for an average of 25 years and none less than 13 years. In this group of 14, there have been five deaths, three patients severely disabled, two partially disabled, and four good recoveries. This reflects the increasing morbidity and mortality with time in this condition. Approximately 50% of the patients with hemorrhage had an initial focal neurological deficit, most often hemiparesis or a visual field defect. This percentage of neurological deficits is higher than that associated with cerebral aneurysm, whereas the mortality from the initial hemorrhage of arteriovenous malformation does not approach that of aneurysm. This difference is probably because the hemorrhage in arteriovenous malformations is usually venous while that from aneurysms is primarily arterial. Also, intracerebral hemorrhage is more common in arteriovenous malformation while subarachoid hemorrhage is usual in cerebral aneurysms.
Hemorrhages
Epilepsy. Epilepsy was the initial symptom in 26 patients. The average age of onset was 33 years. Of the 26 patients, 14 had only focal seizures, nine had only generalized seizures, three had both. Those lesions located around the paracentral area are the most likely to produce seizures, and there is variability not only between the patients but also in the periodicity of seizures.
The patients that had seizures initially have been followed for an average of 12.5 years ( Table 4) . Fourteen of these subsequently remained seizure free, five have significant deficit but are employed, and four are disabled. There have been three deaths in this group. In only four patients has there been subsequent intracerebral hemorrhage.
Mental Changes. Mental changes have not been a frequent symptom in this series. Attempts have been made to correlate mental changes with the age of the patient, the size and location of the lesion, and the length of the symptoms. Mental changes have been explained by the shunting of the circulation of the brain surrounding the arteriovenous malformation, repeated small hemorrhages with softening and gliosis, or pathological changes secondary to repeated seizures. Six of our patients have had some personality change or unusual emotional lability. Two of these have been admitted at one time or another to a mental institution.
Posterior Fossa Lesions. Five arteriovenous malformations were located in the posterior fossa (Table 5 ). The initial symptom was trigeminal neuralgia in three patients at the age of 28, 34, and 37, an early age for idiopathic tic douloureux. Hemifacial spasm developed later in one patient. Two patients are working full time with little dis- ability, but the third patient has been followed 8 years and is disabled with ataxia, slurred speech, and mental confusion; hydrocephalus developed and she improved somewhat following a ventriculo-atrial shunt. One of the other two patients is doing well, and one died from an intracerebral hemorrhage following a shunting procedure for progressive hydrocephalus (Fig. 1 ) .
Associated Observations
Pregnancy. The question often arises as to the advisability of pregnancy and subsequent delivery in women with known arteriovenous malformations. Of the 15 married women in this series, 10 have at least one child and one has four children. Only one patient had a hemorrhage during either pregnancy or delivery; this was a woman with three children who bled in the first trimester with her last child. These data on an admittedly small number of patients suggest that no definite correlation exists between pregnancy and delivery and intracerebral hemorrhage secondary to arteriovenous malformation.
A neurysms. As Perret and Nishioka s noted, there is a slightly increased incidence of intracranial aneurysms in association with arteriovenous malformations. Only two of our 70 patients had intracranial aneurysms, one of the anterior communicating artery and the other of the middle cerebral. The latter bled from the aneurysm and was treated surgically with good results; in the former, the bleeding was thought to be secondary to the arteriovenous malformation and therefore the aneurysm was not approached surgically.
Increased Angioma Size. Statements that these angiomas frequently increase in size or number of vessels have been poorly documented. Few serial studies have been carried out, and the interpretation of the follow-up angiogram may be difficult because of variations in technique and changes in radiologic equipment and timing. We have follow-up angiographic studies in five patients. Two patients showed no change in the size of the lesion 2 and 3 years later; one patient showed a decrease in the size of the arteriovenous malformation, and less uptake was demonstrated on the brain scan on the follow-up examination; two patients had very slight increase in the size and number of vessels on angiograms made 10 and 6 years apart.
Plain X-Ray Films. These were of value in only 5 of 70 patients. Three had intracranial calcifications, one had enlarged venous channels in the frontal area, and one had increase in the size of the foramen lacerum (Fig. 2) .
Bruit. A bruit was heard over the head in only 12 patients.
Radioisotopic Brain Scanning
The radioisotopic brain scan proved to be a useful examination. Of the 60 scans made, 74% localized the lesion correctly. The first 14 scans were positive; fortuitously, these were performed on patients with large lesions. Initially, ~97mercury chlormerodrin (700 to 1,000 pc) was used, but 99mTc pertechnetate proved to be a somewhat better agent and is the radiopharmaceutical we currently use. On reviewing the scans for arteriovenous malformations, we had the impression that 99mTc gave a superior scan. We have attempted to make repeated scans on many of our patients and at present we have at least one scan on 43 patients. Seventeen patients have had scans performed with both 99mTc and ~grHg. Thirty-two of the 43 patients have had positive scans.
A n effort has been made to correlate the size and location of the lesion and its configuration with the brain scan. The study indicates that all large lesions in the range of 6 to 10 cm in diameter have had a definitely positive scan (Fig. 3) . Those lesions 4 to 5 cm in diameter have had positive scans but less strikingly so (Fig. 4) . Lesions less than 2 to 3 cm in greatest diameter failed to show on scans in 1 1 patients; these lesions were often located near the midline. In 17 patients who had both 197Hg and 99mTc scans, there was no discrepency in the interpretation in a comparison of both agents; however, 99mTc seems to define the lesion more clearly.
We were unable on the basis of the configuration of the brain scan itself to predict whether the lesion was an arteri0venous malformation or a tumor. In general, the very large arteriovenous malformations were triangular in shape, although this was quite variable and could be misleading. In an effort to gain more information, we are now using a scintillation camera to perform rapid sequence studies at the time of injecting the radiopharmaceutical agent. We believe that this will distinguish between arteriovenous malformations, meningiomas, and vascular gliomas.
Operative Intervention
In eight patients in this series the lesion was excised; this group has been followed for an average of 9 years. Six have had excellent results. There has been no operative mortality. One patient died from a gastric hemorrhage while in a mental institution several years following operation, and another is partially disabled by a visual field defect.
Usually patients have been selected for operative intervention who have a history of hemorrhage and a lesion whose location will allow resection without unacceptable neurological deficit. In general, seizures alone are not an indication for operation, since they can almost always be controlled with medication and the incidence of seizures following resection remains quite high. The choice of treatment in the majority of patients has been obvious, indicated either by the large size (Fig. 5) or the location (Fig. 6) or the position of the lesion. As operative techniques and new methods are developed and as the natural history of the disease becomes clearer, a greater number of these lesions m a y be removed without serious morbidity and mortality.
Summary and Conclusions
A diagnosis of cerebral arteriovenous malformation was made in 70 patients treated at the North Carolina Baptist Hospital from 1949 to 1969. Data derived from this group of patients have provided the basis for the natural history, location, clinical presentation, morbidity, and mortality in these lesions.
In the diagnostic work-up of these patients, 60 radioisotopic brain scans were performed; they correctly localized 7 4 % of the arteriovenous malformations. In an effort to understand the false-negative scans, a correlation was made in each case between the cerebral angiogram and the brain scan. It was found that the size and location of the arteriovenous malformation was directly related to its detection by the brain scan. All lesions 6 to 10 cm in size had definitely positive scans; those between 4 and 5 cm in greatest diameter were localized but less positively; and lesions 3 cm in size or less were not visualized. Lesions peripherally located were more clearly depicted than those centrally placed, particularly if they were as large as 4.5 cm. It was concluded that the radioisotopic brain scan, in spite of the 25 % false-negative studies, was an excellent screening procedure for the detection of arteriovenous malformations.
